ADHD Interventions + Stimulant for ADHD
Trial Summary
What is the purpose of this trial?
This trial tests different ways to help children with ADHD behave better in school. It starts with general classroom techniques, adds more focused help if needed, and uses advanced methods or medication if necessary. The study targets young children with ADHD who are not in special education or on medication. Medication has been extensively studied and shown to improve ADHD symptoms in children.
Will I have to stop taking my current medications?
The trial does not specify if participants must stop taking their current medications. However, children with a history of successful treatment with stimulant medication are excluded from the study.
What data supports the effectiveness of this treatment for ADHD?
Is the combination of ADHD interventions and stimulants safe for humans?
How is the Tier 1 Classroom Management treatment for ADHD different from other treatments?
Tier 1 Classroom Management is unique because it involves teachers using specific strategies to manage behavior in the classroom, rather than relying solely on medication. This approach focuses on creating a structured environment and using behavior therapy techniques to help students with ADHD, which can also positively impact their classmates.148910
Research Team
Eligibility Criteria
This trial is for children in grades 1-5 diagnosed with ADHD according to DSM-V criteria. It's not suitable for kids who've had successful ADHD treatment with stimulants, those in special education due to behavior issues, have an IQ under 70, psychosis or pervasive developmental disorders, are already part of the study, or are home-schooled.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Tier 1 Intervention
Participants receive Tier 1 classroom-wide management strategies as part of the RTI approach
Tier 2 Intervention
Participants who do not respond to Tier 1 receive a Daily Report Card (DRC) intervention
Enhanced RTI or Medication
Participants who do not respond to Tier 2 are randomly assigned to either enhanced RTI strategies or receive stimulant medication
Follow-up
Participants are monitored for safety and effectiveness after interventions
Treatment Details
Interventions
- Daily Report Card (DRC) (Behavioural Intervention)
- Enhanced DRC (DRC-E) (Behavioural Intervention)
- Stimulant (Hormone Therapy)
- Tier 1 Classroom Management (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Florida International University
Lead Sponsor
Andrés G. Gil
Florida International University
Chief Executive Officer
PhD in Medical Sociology from the University of Miami
Dr. Stuart Hart
Florida International University
Chief Medical Officer
MD from Harvard Medical School
University at Buffalo
Collaborator
Satish K. Tripathi
University at Buffalo
Chief Executive Officer since 2011
PhD in Computer Science from University of Toronto
Brian M. Parker
University at Buffalo
Chief Medical Officer since 2021
MD from University of Pennsylvania